{"id":294360,"date":"2026-10-08T11:37:22","date_gmt":"2026-10-08T06:07:22","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=294360"},"modified":"2026-10-08T11:37:22","modified_gmt":"2026-10-08T06:07:22","slug":"healthcare-services-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/","title":{"rendered":"3 Healthcare Services Stocks With a Strong Future Roadmap: Yatharth Hospital &#038; Trauma Care Services, Shalby and Krsnaa Diagnostics"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Yatharth Hospital Rs 1,032.70, P\/E 57.12. Shalby Rs 134.62, P\/E 38.67. Krsnaa Diagnostics Rs 548.10, P\/E 18.23. Closing prices of 7 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Healthcare services stocks with the clearest long-term roadmaps today include Yatharth Hospital &#038; Trauma Care Services in multi-speciality hospitals in the Delhi NCR region, Shalby in joint replacement hospitals and orthopaedic implants and Krsnaa Diagnostics in diagnostic services through government partnerships. FY26 revenue growth was 37.5% at Yatharth Hospital, 4.8% at Shalby and 9.9% at Krsnaa Diagnostics. P\/E stands at 57.12 for Yatharth Hospital (industry 62.71), 38.67 for Shalby (industry 62.71) and 18.23 for Krsnaa Diagnostics (industry 62.71). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Healthcare services stocks give investors exposure to hospitals, joint replacement centres and diagnostic networks. Results depend on bed occupancy, patient volumes and contract wins, which is why capacity use matters as much as headline growth.<\/p>\n<p>This list covers three regional hospital and diagnostic chain stocks: Yatharth Hospital &#038; Trauma Care Services for multi-speciality hospitals in the Delhi NCR region, Shalby for joint replacement hospitals and orthopaedic implants and Krsnaa Diagnostics for diagnostic services through government partnerships. Every figure comes from the latest reported financials and the 7 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=healthcare-services-stocks-strong-roadmap\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#What_Are_Healthcare_Services_Stocks\" title=\"What Are Healthcare Services Stocks?\">What Are Healthcare Services Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Healthcare_Services_Stocks_at_a_Glance\" title=\"Healthcare Services Stocks at a Glance\">Healthcare Services Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Why_Do_Healthcare_Services_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Healthcare Services Stocks Have a Strong Roadmap in India?\">Why Do Healthcare Services Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Yatharth_Hospital_Trauma_Care_Services_Multi-Speciality_Hospitals_in_NCR_Anchor_the_Roadmap\" title=\"Yatharth Hospital &#038; Trauma Care Services: Multi-Speciality Hospitals in NCR Anchor the Roadmap\">Yatharth Hospital &#038; Trauma Care Services: Multi-Speciality Hospitals in NCR Anchor the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Shalby_Joint_Replacement_and_Implants_Drive_the_Pipeline\" title=\"Shalby: Joint Replacement and Implants Drive the Pipeline\">Shalby: Joint Replacement and Implants Drive the Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Krsnaa_Diagnostics_Government_Diagnostic_Partnerships_Build_the_Next_Leg\" title=\"Krsnaa Diagnostics: Government Diagnostic Partnerships Build the Next Leg\">Krsnaa Diagnostics: Government Diagnostic Partnerships Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Best_Healthcare_Services_Stocks_in_India_Yatharth_Hospital_vs_Shalby_vs_Krsnaa_Diagnostics_on_Key_Financials\" title=\"Best Healthcare Services Stocks in India: Yatharth Hospital vs Shalby vs Krsnaa Diagnostics on Key Financials\">Best Healthcare Services Stocks in India: Yatharth Hospital vs Shalby vs Krsnaa Diagnostics on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#How_to_Evaluate_Hospital_and_Diagnostics_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Hospital and Diagnostics Stocks to Buy Before You Invest\">How to Evaluate Hospital and Diagnostics Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Risks_to_Consider_Before_Investing_in_Healthcare_Services_Stocks\" title=\"Risks to Consider Before Investing in Healthcare Services Stocks\">Risks to Consider Before Investing in Healthcare Services Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#FAQs_on_Healthcare_Services_Stocks\" title=\"FAQs on Healthcare Services Stocks\">FAQs on Healthcare Services Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Which_are_the_best_healthcare_services_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best healthcare services stocks in India with a strong roadmap?\">Which are the best healthcare services stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Is_Yatharth_Hospital_Trauma_Care_Services_a_good_stock_to_buy_now\" title=\"Is Yatharth Hospital &#038; Trauma Care Services a good stock to buy now?\">Is Yatharth Hospital &#038; Trauma Care Services a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#What_is_the_PE_ratio_of_Yatharth_Hospital_Shalby_and_Krsnaa_Diagnostics\" title=\"What is the P\/E ratio of Yatharth Hospital, Shalby and Krsnaa Diagnostics?\">What is the P\/E ratio of Yatharth Hospital, Shalby and Krsnaa Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Which_of_these_healthcare_services_stocks_has_the_highest_return_on_equity\" title=\"Which of these healthcare services stocks has the highest return on equity?\">Which of these healthcare services stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#What_are_the_risks_of_investing_in_healthcare_services_stocks\" title=\"What are the risks of investing in healthcare services stocks?\">What are the risks of investing in healthcare services stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#How_did_Yatharth_Hospital_Shalby_and_Krsnaa_Diagnostics_perform_in_Q1_FY27\" title=\"How did Yatharth Hospital, Shalby and Krsnaa Diagnostics perform in Q1 FY27?\">How did Yatharth Hospital, Shalby and Krsnaa Diagnostics perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#Do_healthcare_services_stocks_pay_dividends\" title=\"Do healthcare services stocks pay dividends?\">Do healthcare services stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/healthcare-services-stocks-strong-roadmap\/#How_can_I_invest_in_healthcare_services_stocks_in_India\" title=\"How can I invest in healthcare services stocks in India?\">How can I invest in healthcare services stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Healthcare_Services_Stocks\"><\/span><strong>What Are Healthcare Services Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Healthcare services stocks are shares of companies that run hospitals or diagnostic networks. Results depend on bed occupancy, patient mix, test volumes, payer rates and operating margin, so full beds and steady contracts separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Healthcare_Services_Stocks_at_a_Glance\"><\/span><strong>Healthcare Services Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three healthcare services stocks as of the 7 October 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/yatharth\/yatharth-hospital-and-trauma-care-services-ltd-share-price-today\">Yatharth Hospital &#038; Trauma Care Services<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,032.70<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,967<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">57.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.71<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.85%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/shalby\/shalby-ltd-share-price-today\">Shalby<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">134.62<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,449<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.67<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.71<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.72%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/krsnaa\/krsnaa-diagnostics-ltd-share-price-today\">Krsnaa Diagnostics<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">548.10<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,776<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.23<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.71<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.35%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.55<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among regional hospital and diagnostic chain stocks, all three trade below their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Healthcare_Services_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Healthcare Services Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Healthcare services stocks have a strong roadmap in India because insurance cover is widening, smaller cities need more beds and governments partner with private players for diagnostics. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Wider insurance cover:<\/strong> More patients can afford hospital care.<\/li>\n<li><strong>Regional capacity gaps:<\/strong> Cities outside the metros need more beds.<\/li>\n<li><strong>Public-private diagnostics:<\/strong> Government partnerships create steady test volumes.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Yatharth_Hospital_Trauma_Care_Services_Multi-Speciality_Hospitals_in_NCR_Anchor_the_Roadmap\"><\/span><strong>Yatharth Hospital &#038; Trauma Care Services: Multi-Speciality Hospitals in NCR Anchor the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Yatharth Hospital&#8217;s roadmap rests on multi-speciality hospitals in the Delhi NCR region, with new beds and acquisitions lifting patient volumes.<\/p>\n<p>Revenue grew from Rs 402.59 crore in FY22 to Rs 1,232.96 crore in FY26, a 206.3% rise, and FY26 revenue was 37.5% higher than FY25. FY26 net profit rose 30.5% to Rs 170.31 crore. Over four years, net profit rose from Rs 44.16 crore in FY22 to Rs 170.31 crore. In Q1 FY27, revenue grew 48.6% to Rs 397.00 crore, and net profit rose 8.0% to Rs 45.42 crore. Operating margin was 27.35% in FY26 and 24.46% in Q1 FY27 against 28.63% a year earlier.<\/p>\n<p>Debt to equity is 0.15 and return on equity is 9.85%. FY26 operating cash flow was Rs 204.52 crore against capital expenditure of Rs 316.54 crore. At a P\/E of 57.12 against an industry P\/E of 62.71, the stock trades below its industry multiple.<\/p>\n<p>What to watch: FY26 capex of Rs 316.54 Cr was above operating cash flow of Rs 204.52 Cr, and the Q1 FY27 operating margin of 24.46% was below the 28.63% of a year earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Shalby_Joint_Replacement_and_Implants_Drive_the_Pipeline\"><\/span><strong>Shalby: Joint Replacement and Implants Drive the Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Shalby&#8217;s roadmap rests on joint replacement hospitals and orthopaedic implants, with new hospitals and overseas implant sales supporting revenue.<\/p>\n<p>Revenue grew from Rs 711.37 crore in FY22 to Rs 1,168.22 crore in FY26, a 64.2% rise, and FY26 revenue was 4.8% higher than FY25. FY26 net profit rose from Rs 1.92 crore to Rs 34.68 crore. In Q1 FY27, revenue grew 11.6% to Rs 338.63 crore, and net profit rose 36.7% to Rs 10.50 crore. Operating margin was 14.37% in FY26 and 14.79% in Q1 FY27 against 16.38% a year earlier.<\/p>\n<p>Debt to equity is 0.59 and return on equity is 3.72%. FY26 operating cash flow was negative at Rs 0.01 crore against capital expenditure of Rs 149.05 crore. At a P\/E of 38.67 against an industry P\/E of 62.71, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The Q1 FY27 operating margin of 14.79% was below the 16.38% of a year earlier, and FY26 revenue growth was only 4.8%. Operating cash flow was negative in FY26.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Krsnaa_Diagnostics_Government_Diagnostic_Partnerships_Build_the_Next_Leg\"><\/span><strong>Krsnaa Diagnostics: Government Diagnostic Partnerships Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Krsnaa&#8217;s roadmap rests on diagnostic services through government partnerships, with new contracts and tests supporting volumes.<\/p>\n<p>Revenue grew from Rs 470.36 crore in FY22 to Rs 816.16 crore in FY26, a 73.5% rise, and FY26 revenue was 9.9% higher than FY25. FY26 net profit rose 30.7% to Rs 101.43 crore. Over four years, net profit rose from Rs 68.39 crore in FY22 to Rs 101.43 crore. In Q1 FY27, revenue grew 23.3% to Rs 242.77 crore, and net profit fell 19.3% to Rs 16.55 crore. Operating margin was 32.62% in FY26 and 27.69% in Q1 FY27 against 28.68% a year earlier.<\/p>\n<p>Debt to equity is 0.55 and return on equity is 10.35%. FY26 operating cash flow was Rs 143.10 crore against capital expenditure of Rs 219.26 crore. Krsnaa Diagnostics paid a dividend of Rs 2 per share for FY26, a yield of 0.37%. At a P\/E of 18.23 against an industry P\/E of 62.71, the stock trades below its industry multiple.<\/p>\n<p>What to watch: FY26 capex of Rs 219.26 Cr was above operating cash flow of Rs 143.10 Cr, and FY26 revenue growth was only 9.9%. Q1 FY27 net profit was 19.3% lower than a year earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Healthcare_Services_Stocks_in_India_Yatharth_Hospital_vs_Shalby_vs_Krsnaa_Diagnostics_on_Key_Financials\"><\/span><strong>Best Healthcare Services Stocks in India: Yatharth Hospital vs Shalby vs Krsnaa Diagnostics on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best healthcare services stocks in India, Krsnaa Diagnostics leads on FY26 operating margin and return on equity; Yatharth Hospital leads on Q1 FY27 revenue growth and five-year revenue growth. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Yatharth Hospital<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Shalby<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Krsnaa Diagnostics<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,232.96<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,168.22<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">816.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Revenue growth FY22 to FY26<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">206.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">64.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">73.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">170.31<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.68<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">101.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.1x<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating profit margin<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.35%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.37%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.62%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">48.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 net profit growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">-19.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.85%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.72%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">57.12<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">38.67<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.23<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.15<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.00%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.37%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 operating cash flow (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">204.52<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">-0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">143.10<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare earnings follow occupancy and test volumes, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Hospital_and_Diagnostics_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Hospital and Diagnostics Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen healthcare services stocks and shortlist hospital and diagnostics stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which is 62.71 for all three here.<\/li>\n<li>Track operating margin across several quarters, because input costs can move faster than prices.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these healthcare services stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Healthcare_Services_Stocks\"><\/span><strong>Risks to Consider Before Investing in Healthcare Services Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Cash flow:<\/strong> Shalby&#8217;s operating cash flow was about zero in FY26 against capex of Rs 149.05 Cr.<\/li>\n<li><strong>Quarterly profit:<\/strong> Krsnaa&#8217;s Q1 FY27 net profit was 19.3% lower than a year earlier.<\/li>\n<li><strong>Low returns:<\/strong> Shalby&#8217;s ROE is 3.72% and Yatharth&#8217;s 9.85%.<\/li>\n<li><strong>Expansion spending:<\/strong> Yatharth&#8217;s FY26 capex of Rs 316.54 Cr was above its operating cash flow of Rs 204.52 Cr.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Yatharth Hospital, Shalby and Krsnaa Diagnostics live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three hospital and diagnostics stocks cover multi-speciality hospitals, joint replacement and implants, and government diagnostic partnerships. Krsnaa Diagnostics leads on FY26 operating margin and return on equity; Yatharth Hospital leads on Q1 FY27 revenue growth and five-year revenue growth.<\/p>\n<p>Across regional hospital and diagnostic chain stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the hospital and diagnostics stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Healthcare_Services_Stocks\"><\/span><strong>FAQs on Healthcare Services Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_healthcare_services_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best healthcare services stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yatharth Hospital &#038; Trauma Care Services, Shalby and Krsnaa Diagnostics stand out for their roadmaps in hospitals, joint replacement and diagnostics. FY26 revenue growth was 37.5% at Yatharth Hospital, 4.8% at Shalby and 9.9% at Krsnaa Diagnostics, and return on equity ranges from 3.72% to 10.35%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Yatharth_Hospital_Trauma_Care_Services_a_good_stock_to_buy_now\"><\/span><strong>Is Yatharth Hospital &#038; Trauma Care Services a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yatharth Hospital &#038; Trauma Care Services has a debt to equity ratio of 0.15, a return on equity of 9.85% and a P\/E of 57.12 against an industry P\/E of 62.71. Cash flow, quarterly profit and low returns move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Yatharth_Hospital_Shalby_and_Krsnaa_Diagnostics\"><\/span><strong>What is the P\/E ratio of Yatharth Hospital, Shalby and Krsnaa Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 57.12 for Yatharth Hospital (industry 62.71), 38.67 for Shalby (industry 62.71) and 18.23 for Krsnaa Diagnostics (industry 62.71). All three trade below the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_healthcare_services_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these healthcare services stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Krsnaa Diagnostics has the highest return on equity at 10.35%, followed by Yatharth Hospital &#038; Trauma Care Services at 9.85% and Shalby at 3.72%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_healthcare_services_stocks\"><\/span><strong>What are the risks of investing in healthcare services stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are weak cash flow at one firm, a weaker quarter at another, low returns on equity and expansion spending. Krsnaa&#8217;s Q1 FY27 net profit was 19.3% lower than a year earlier.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Yatharth_Hospital_Shalby_and_Krsnaa_Diagnostics_perform_in_Q1_FY27\"><\/span><strong>How did Yatharth Hospital, Shalby and Krsnaa Diagnostics perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yatharth Hospital &#038; Trauma Care Services reported revenue of Rs 397.00 crore, up 48.6% year on year, and net profit rose 8.0% to Rs 45.42 crore. Shalby reported revenue of Rs 338.63 crore, up 11.6% year on year, and net profit rose 36.7% to Rs 10.50 crore. Krsnaa Diagnostics reported revenue of Rs 242.77 crore, up 23.3% year on year, and net profit fell 19.3% to Rs 16.55 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_healthcare_services_stocks_pay_dividends\"><\/span><strong>Do healthcare services stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Dividend payouts differ across the three companies. The dividend yield is 0.00% for Yatharth Hospital, 0.00% for Shalby and 0.37% for Krsnaa Diagnostics, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_healthcare_services_stocks_in_India\"><\/span><strong>How can I invest in healthcare services stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy healthcare services stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best healthcare services stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yatharth Hospital & Trauma Care Services, Shalby and Krsnaa Diagnostics stand out for their roadmaps in hospitals, joint replacement and diagnostics. FY26 revenue growth was 37.5% at Yatharth Hospital, 4.8% at Shalby and 9.9% at Krsnaa Diagnostics, and return on equity ranges from 3.72% to 10.35%.\"}},{\"@type\":\"Question\",\"name\":\"Is Yatharth Hospital & Trauma Care Services a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yatharth Hospital & Trauma Care Services has a debt to equity ratio of 0.15, a return on equity of 9.85% and a P\/E of 57.12 against an industry P\/E of 62.71. Cash flow, quarterly profit and low returns move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Yatharth Hospital, Shalby and Krsnaa Diagnostics?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 57.12 for Yatharth Hospital (industry 62.71), 38.67 for Shalby (industry 62.71) and 18.23 for Krsnaa Diagnostics (industry 62.71). All three trade below the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these healthcare services stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Krsnaa Diagnostics has the highest return on equity at 10.35%, followed by Yatharth Hospital & Trauma Care Services at 9.85% and Shalby at 3.72%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in healthcare services stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are weak cash flow at one firm, a weaker quarter at another, low returns on equity and expansion spending. Krsnaa's Q1 FY27 net profit was 19.3% lower than a year earlier.\"}},{\"@type\":\"Question\",\"name\":\"How did Yatharth Hospital, Shalby and Krsnaa Diagnostics perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yatharth Hospital & Trauma Care Services reported revenue of Rs 397.00 crore, up 48.6% year on year, and net profit rose 8.0% to Rs 45.42 crore. Shalby reported revenue of Rs 338.63 crore, up 11.6% year on year, and net profit rose 36.7% to Rs 10.50 crore. Krsnaa Diagnostics reported revenue of Rs 242.77 crore, up 23.3% year on year, and net profit fell 19.3% to Rs 16.55 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do healthcare services stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dividend payouts differ across the three companies. The dividend yield is 0.00% for Yatharth Hospital, 0.00% for Shalby and 0.37% for Krsnaa Diagnostics, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in healthcare services stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy healthcare services stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Yatharth Hospital &#038; Trauma Care Services, Shalby and Krsnaa Diagnostics compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":38,"featured_media":294359,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[10051,10052,10055,10054,10053],"class_list":["post-294360","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-healthcare-services-stocks","tag-hospital-and-diagnostics-stocks","tag-krsnaa-diagnostics","tag-shalby","tag-yatharth-hospital-trauma-care-services"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["294359"],"rank_math_title":["Healthcare Services Stocks: Yatharth Hospital, Shalby and More"],"rank_math_description":["Healthcare services stocks with a strong roadmap: Yatharth Hospital, Shalby and Krsnaa Diagnostics compared on growth, margins, valuation and risks. Oct 2026 data."],"rank_math_focus_keyword":["healthcare services stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-healthcare-services-stocks-with-a-strong-future-roadmap-yatharth-hospital-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/294360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=294360"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/294360\/revisions"}],"predecessor-version":[{"id":294361,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/294360\/revisions\/294361"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/294359"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=294360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=294360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=294360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}